BioIQ, Matrix Medical promote employer COVID-19 testing program

2020 03 12 17 37 4721 Virus Coronavirus3 400

BioIQ and Matrix Medical Network are combining expertise to help U.S. companies make it safer for their employees to return to work when the COVID-19 virus comes under control enough to allow reopening of economies.

The companies will collaborate to create COVID-19 testing, protocol, assessment, and monitoring programs through Matrix's national array of locally based providers paired with BioIQ's technology and testing platform. The initiative also would allow for COVID-19 testing at employer locations, as well as community, retail, and drive-through testing sites.

The COVID-19 testing platform and integrated lab network would feature reverse transcription polymerase chain reaction (RT-PCR) SARS-CoV-2 diagnostic testing and quantitative lab-based immunoglobulin M/immunoglobulin G (IgM/IgG) antibody testing. In addition, the companies want to promote on-premises fever and symptom checking, telehealth clinical guidance, and employee population analytics.

Page 1 of 150
Next Page